Buffington Mohr McNeal Has $326,000 Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Buffington Mohr McNeal cut its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 6.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,705 shares of the company’s stock after selling 345 shares during the quarter. Buffington Mohr McNeal’s holdings in Henry Schein were worth $326,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Olstein Capital Management L.P. increased its stake in Henry Schein by 17.2% in the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock valued at $7,543,000 after buying an additional 16,000 shares during the period. Fifth Third Bancorp raised its holdings in Henry Schein by 11.0% during the fourth quarter. Fifth Third Bancorp now owns 3,366 shares of the company’s stock valued at $233,000 after buying an additional 333 shares in the last quarter. Merit Financial Group LLC boosted its stake in shares of Henry Schein by 15.8% during the 4th quarter. Merit Financial Group LLC now owns 23,137 shares of the company’s stock worth $1,601,000 after acquiring an additional 3,156 shares in the last quarter. Sendero Wealth Management LLC raised its stake in shares of Henry Schein by 7.9% in the 4th quarter. Sendero Wealth Management LLC now owns 12,261 shares of the company’s stock valued at $848,000 after acquiring an additional 898 shares in the last quarter. Finally, Signal Advisors Wealth LLC lifted its holdings in Henry Schein by 15.5% in the 4th quarter. Signal Advisors Wealth LLC now owns 5,382 shares of the company’s stock worth $372,000 after purchasing an additional 723 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC opened at $76.69 on Tuesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The business’s fifty day moving average price is $73.04 and its two-hundred day moving average price is $71.14. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The stock has a market capitalization of $9.56 billion, a price-to-earnings ratio of 31.56, a price-to-earnings-growth ratio of 2.04 and a beta of 0.89.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company’s revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.32 earnings per share. As a group, analysts predict that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

HSIC has been the topic of a number of recent analyst reports. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Barrington Research reissued an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research report on Wednesday, November 6th. Mizuho started coverage on Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target on the stock. Evercore ISI increased their target price on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Finally, Jefferies Financial Group lifted their price target on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Seven investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $79.30.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.